Glaxo-Smith-Kline agreed to pay $750 million to settle a case involving defective drugs. As far as I can tell, no definite harm from these drugs was documented.
That’s what I love about our health care system. The level of safety we expect is extraordinarily high. FDA rules on drugs demand an extraordinary level of safety expectation.
When people ask me what I think of “natural” treatments for their conditions, I tell them that I feel much safer with an actual medication, because our medications are extraordinarily well-defined and safe. Reputable American pharmaceutical companies don’t take chances. The risk to them of making a mistake, as GSK did here, are enormous.